- Home
- H vs FMS Comparison
H vs FMS Comparison
Compare H & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | H | FMS |
|---|---|---|
| Founded | 1957 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 13.5B |
| IPO Year | 2009 | 1996 |
Fundamental Metrics
Financial Performance| Metric | H | FMS |
|---|---|---|
| Price | $165.03 | $23.59 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 16 | 2 |
| Target Price | ★ $160.13 | $30.00 |
| AVG Volume (30 Days) | ★ 778.7K | 450.8K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | 0.37% | ★ 2.42% |
| EPS Growth | N/A | ★ 8.62 |
| EPS | N/A | ★ 2.86 |
| Revenue | $3,339,000,000.00 | ★ $23,046,819,198.00 |
| Revenue This Year | $120.45 | $2.12 |
| Revenue Next Year | $4.12 | $2.92 |
| P/E Ratio | ★ N/A | $15.93 |
| Revenue Growth | N/A | ★ 2.10 |
| 52 Week Low | $102.43 | $22.05 |
| 52 Week High | $168.10 | $30.46 |
Technical Indicators
Market Signals| Indicator | H | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 64.15 | 46.30 |
| Support Level | $151.64 | $22.63 |
| Resistance Level | $163.80 | $24.20 |
| Average True Range (ATR) | 3.95 | 0.28 |
| MACD | 0.01 | 0.12 |
| Stochastic Oscillator | 86.96 | 61.14 |
Price Performance
Historical ComparisonAbout H Hyatt Hotels Corporation
Hyatt is an operator of owned (3% of total rooms) and managed and franchised (97%) properties across about 30 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva, and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, the wellness brand Miraval, and the midscale extended-stay brand Studios. Hyatt acquired Two Roads Hospitality in 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 63% Americas, 15% rest of world, and 22% Asia-Pacific.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.